Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Power-TIL LM303
- Development stage
- Unknown
- Lead developer
- Suzhou Lanma Medical Technology
- Modality
- Gene Therapies, Tumor-Infiltrating Lymphocytes (TILs) → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Intravenous
01
Overview
Power-TIL LM303 is a genetically modified tumor-infiltrating lymphocyte (TIL) cell therapy being developed by Suzhou Lanma Medical Technology Co. Ltd. for the treatment of advanced solid tumors, including non-small cell lung cancer and uterine cervical cancer. Unlike conventional TIL therapies, LM303 is genetically engineered to enhance anti-tumor activity and overcome the immunosuppressive tumor microenvironment, although the specific genetic modifications have not been publicly disclosed. It is currently being evaluated in exploratory clinical studies to assess its safety, efficacy, and immunoreactivity in patients with refractory solid tumors.
- Other names
- LM303 InjectionLM-303 InjectionLM 303 Injection
Beyond the preview
Go deeper on Power-TIL LM303.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Power-TIL LM303.